SEC Form 4 · accession 0001513162-18-000171
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis H Titterton Jr.
Director
Period of report
Jul 26, 2018
Accepted (ET)
Jul 27, 2018 · 4:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock OptionF1 | $3.46 | Jul 26, 2018 | A | 300,000 | A | — | Jul 26, 2028 | Common Stock | 300,000 | 300,000 | D |
Explanation of responses
- F1The option vests and becomes exercisable in equal installments on a quarterly basis over three years beginning on October 31, 2018.